Seattle-based biotech company Curi Bio has signed a lease with BioMed Realty with plans to relocate to a 13,942-square-foot space in Interbay.
The biotech occupies roughly 6,000 square feet at 3000 Western Ave. now, according to Eric Swanson, Curi Bio’s vice president of operations. It is still finalizing its moving plans for the new space at 201 Elliott Ave. W, but Swanson said the goal is to move during the first quarter of 2025.
“We wanted some more room to expand,” Swanson said. “It gives us room to grow our operations and grow some of our research efforts and grow our team a little bit over the years.”